Role of Patients in Management of MPN
Dr. Ruben A. Mesa

Chair, Myeloproliferative Neoplasm Guideline Panel - National Comprehensive Cancer Network (NCCN)

Director, UT Health San Antonio Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA


 

Education

1991 - 1995

M.D. of Medicine, Mayo Medical School, Mayo Clinic College of Medicine, Rochester, Minnesota, USA

1987 - 1991

B.S. in Nuclear Engineering and Physiology, University of Illinois at Urbana-Champaign, Champaign, Illinois, USA

 

Professional Experience

2017 - Present

Director, UT Health San Antonio Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

2017 - Present

Mays Family Foundation Distinguished University Chair, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

2017 - Present

Tenured Professor of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

2015 - Present

Chair, Myeloproliferative Neoplasm Guideline Panel - National Comprehensive Cancer Network (NCCN)

2012 - 2017

Deputy Director, Mayo Clinic Cancer Center, USA

2009 - 2012

Director, Acute and Chronic Leukemia Program, Mayo Clinic, Scottsdale, Arizona, USA

1998 - 2002

Fellow, Hematology/Medical Oncology, Mayo Graduate School of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA

1995 - 1998

Resident, Internal Medicine, Mayo Graduate School of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA